Beta Sheets, Mutations, and Orthomolecular Inhibitors, Oh My: A Comparison of Beta-Sheet Production Across Mutants and the Effects of B17 on Inhibition of Fibril Formation  by Reinsalu, Sean C. & Chimon-Peszek, Sandra
242a Monday, February 27, 2012properties. In the first 0.15 microseconds of TVREX simulations, b-sheet and
a-helical aggregates form both at the interface and in the hydrophobic core
of the lipid bilayer. We quantify the extent to which these aggregates compro-
mise the integrity of the lipid bilayer. This analysis indicates that fragments of
human prion peptides and of Alzheimer’s-related apolipoprotein, which form
b-sheet amyloid fibrils in vivo, are capable of forming b-sheet aggregates
that disrupt lipid bilayers. Taken together, our results reveal, in atomistic detail,
a variety of modes by which amyloidogenic peptides may disrupt lipid bilayers,
providing mechanistic insights into the molecular basis of toxicity in this im-
portant class of human diseases.
(1) S. Rauscher, C. Neale and R. Pome`s, J. Chem. Theory Comput., 2009,
5:2640-2662.
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Amyloid-beta protein has been implicated in the pathogenesis of Alzheimer’s
disease for many decades now. However, the exact molecular mechanism by
which it effects neurodegeneration is not yet understood. One promising dis-
ease model is based on the discovery that amyloid-beta forms large pores across
lipid bilayers. These pores cause an uncontrolled flux of ions as well as larger
molecules and can potentially disrupt cell homeostasis. AFM images of
amyloid-beta pores provide an estimate of the size and symmetry of the pores,
but the secondary and tertiary structure of amyloid-beta within the membrane is
unknown. This study tests the stability of a hypothetical pore structure and will
predict the number of monomers within amyloid-beta pores using coarse-
grained molecular dynamics simulations. The change in stability of the pore
structure with changes in membrane composition will also be investigated,
since membrane composition is known to vary with age - the greatest risk factor
for Alzheimer’s disease.Platform: Protein Aggregates
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The mechanism by which amyloid-b (Ab) plaque accumulation contributes to
neurodegeneration in Alzheimer’s disease (AD) remains poorly understood.
With biophysical, thermodynamic and kinetic characterization of the various
Ab structures involved in plaque development, we aim to identify connections
between polymerization cascade events and AD pathogenesis. Herein, we pres-
ent oxidative footprinting with mass spectrometry to probe the solvent accessi-
bility of specific amino acid side chains in Ab40 fibrils and oligomeric forms of
Ab40. These accessibilities are compared to those of a fully exposed reference
state using hydroxyl radicals (*OH) generated either by water radiolysis or by
Fe(II)-EDTA reaction with peroxide. Using this information we distinguish
topological relationships within the fibril to allow selection of the relevant
tertiary structural model of fibrillar Ab from those suggested by NMR and those
by cryogenic electron microscopy. This work provides important steps towards
correlating structure and morphology in Ab fibrils – essential for understanding
the molecular pathogenesis of AD.
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Understanding the structural transitions that amyloid proteins undergo during
amyloidogenesis would greatly enhance our understanding of this process.
However, our knowledge has been currently largely limited to global confor-
mational changes, with high-resolution structural information only available
for the monomeric proteins and for a few structures of the final amyloid prod-
uct. In particular, high-resolution structures of intermediate states have been
notoriously absent with few exceptions. We show here that high-resolution
structures of intermediates can be obtained by using SOFAST-HMQC,
CPMG, NOESY, magic-angle-spinning, and other experiments in real-time
to track the aggregation pathway at atomic-level detail and at a time-resolution of minutes. As examples, we show the aggregation pathways of
Ab and IAPP, two initially unstructured peptides implicated in Alzheimer’s
and type II Diabetes, respectively.
While previous studies commonly show the Ab1-40 is largely unstructured in
solution before the formation of b-sheet oligomers, we show that Ab1-40 grad-
ually adopts a compact, partially folded helical structure over a period of
several days. In this structure, the central hydrophobic region of the peptide
forms a 310 helix from H13 to D23 and the N- and C-termini collapse against
the helix due to the clustering of hydrophobic residues (pdb:2LFM). The forma-
tion of the helical intermediate is concentration dependent and can be partially
reversed by dilution of the peptide. Helical intermediates have been predicted
to be crucial on-pathway intermediates in amyloid fibrillogenesis, and the struc-
ture presented here presents a new target for structure-based intervention,
shown here by the interaction of the helical intermediate with polyphenols.
By contrast, the more amyloidogenic IAPP peptide shows only a gradual tran-
sition to the fiber form after an initial pH dependent formation of a micelle-like
aggregate, with distinct b-sheet small oligomers forming only a small fraction
of the observable population.
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Beta-sheet fibril deposits are a crucial hallmark of Alzheimer’s disease. Char-
acterized by accumulations of highly toxic beta-sheet structures, fibril tangles
disrupt synaptic function causing impaired memory. Amassing toxicity results
in neuronal degradation and ultimately complete brain death. Beta-amyloid
research focuses on one region of the 40-42 amino acid length beta-
amyloid known as ‘‘KLVFFA’’; this region, from residues 16-21, is believed
to be the single, shortest, and most important contributor to beta-sheet forma-
tion. However, these theories overlook the crucial portion of the peptide, at
residues 23-28, containing an ionic interaction inducing a hair pin turn.
This potential rate limiting step in the folding of beta-amyloid provides
new insight into the pathogenesis of Alzheimer’s disease. Cleavage at resi-
dues 22 and 35 excludes the effect of ‘‘KLVFFA’’ and limits secondary fold-
ing interactions of the N-terminus after 35. Spectral analysis of the Wild
Type WT Ab22-35 lays ground work for various single point mutations
within the shorter fragment. Ab-E22G and Ab-D23N, also known as the Arc-
tic mutation and Iowa mutation respectively, are characterized by faster accu-
mulation of amyloid fibrils. Beta-sheet production occurs rapidly, but can be
observed by the implementation of ATR-IR spectroscopy focusing on signa-
ture chemical shifts in the amide one and amide two regions within the pep-
tide. Second, pentamaric binding of multiple secondary beta structures to
Congo-Red dye solution confirms the production of beta-sheets via UV/Vis.
Moreover, time dependant TEM imaging of the WT revealed the presence
of fibrils, demonstrating the importance of studying this shorter fragment.
Suppression of fibril formation by the addition of concentrated orthomolecu-
lar compounds could yield therapeutic techniques or possibly even a cure for
Alzheimer’s disease.
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Starting from a disordered aggregate, we have simulated the formation of
ordered amyloid-like beta structures in a system formed by 18 poly-valine
chains in explicit solvent, by employing molecular dynamics accelerated by
bias-exchange metadynamics. We exploited 8 different collective variables
to compute the free energy of hundreds of putative aggregate structures, with
variable content of parallel and anti-parallel beta-sheets and different packing
among the sheets. This allowed characterizing in detail a possible nucleation
pathway for the formation of amyloid fibrils: first the system forms a relatively
large ordered nucleus of anti-parallel beta-sheets, then a few parallel sheets
start appearing. The relevant nucleation process culminates at this point:
when a sufficient number of parallel sheets is formed, the free energy starts
to decrease towards a new minimum in which this structure is predominant.
The complex nucleation pathway we found cannot be described within classical
nucleation theory, namely employing a unique simple reaction coordinate like
the total content of beta-sheets.
